Exploring the anti-asthmatic effects of HMM: OVA-induced murine model and multi-target in silico analysis
Naunyn-Schmiedeberg's Archives of Pharmacology · 2026-06 · 399 (9) · 14221-14235
DOI: 10.1007/s00210-026-05164-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 13.04.2026. Verfasst von Abdul Rashid Shaikh und 9 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, The University of Lahore, Lahore, 54000, Pakistan. Hauptthemen laut MEDLINE: Anti-Asthmatic Agents, Asthma, Isoxazoles. Die Arbeit nennt 63 Literaturangaben. Gefördert von: King Khalid University.
Abstract (Originalsprache)
Asthma is a widespread chronic inflammatory condition of the airways, often triggered by allergens such as ovalbumin. This study aimed to evaluate the potential anti-asthmatic effects of a synthetic isoxazolone derivative, (Z)-4-(4-hydroxy-3-methoxybenzylidene)-3-methylisoxazole-5(4H)-one (HMM), in a mouse model of allergic asthma. Molecular docking was carried out to explore the HMM interaction with asthma-associated proteins, providing insights into its potential therapeutic targets. Thirty-six albino mice were randomly divided into six groups: negative control, positive control, standard drug group (methylprednisolone, 15 mg/kg), and three groups receiving HMM at doses of 3.2, 6.3, and 12.6 mg/kg. Mice were sensitized with ovalbumin on days 0 and 14, followed by intranasal exposure from days 15 to 21 to induce allergic airway inflammation. Blood and bronchoalveolar lavage fluid (BALF) were collected to measure total and differential leukocyte counts. Cytokine expression (IL-4, IL-5) and aquaporins (AQP-1, AQP-5) were quantified via real-time PCR. HMM-treated groups showed reduced inflammation, lowered Th2 cytokine levels, and improved lung water transport markers. Computational studies supported these findings, revealing strong binding affinities between HMM and TNF-α (- 6.07 kcal/mol), AKT1 (- 6.32 kcal/mol), and COX-2 (- 5.87 kcal/mol), forming stable hydrogen-bond interactions with key active-site residues. These results suggest HMM holds promise as a potential anti-asthmatic agent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmacy, The University of Lahore, Lahore, 54000, Pakistan.
- Faculty of Pharmacy, The University of Lahore, Lahore, 54000, Pakistan. aisha.mobashar@pharm.uol.edu.pk.
- Faculty of Health Sciences, Equator University of Science and Technology, Maska, 133243, Uganda. aisha.mobashar@pharm.uol.edu.pk.
- Department of Pharmacology, Institute of Pharmacy, Faculty of Pharmaceutical and Allied Health Sciences, Lahore College for Women University, Jail Road, Lahore, Pakistan. alisharifpharmacist@gmail.com.
- Department of Pharmacy, Faculty of Health and Pharmaceutical Sciences, University of Agriculture, Faisalabad, 38040, Pakistan.
- Department of Biology, College of Science, King Khalid University, PO Box 960, Asir, Abha, 61421, Saudi Arabia.
Förderung
- King Khalid University
Zitieren
APA
Shaikh, A. R., Mobashar, A., Sharif, A., Akhtar, B., Alghamdi, O. A., Alyami, E. M., Elossaily, G. M., Almohammed, O. A., Metouekel, A., & Bourhia, M. (2026). Exploring the anti-asthmatic effects of HMM: OVA-induced murine model and multi-target in silico analysis. Naunyn-Schmiedeberg's Archives of Pharmacology, 399(9), 14221-14235. https://doi.org/10.1007/s00210-026-05164-5
Vancouver
Shaikh AR, Mobashar A, Sharif A, Akhtar B, Alghamdi OA, Alyami EM, et al. Exploring the anti-asthmatic effects of HMM: OVA-induced murine model and multi-target in silico analysis. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026;399(9):14221-14235. doi:10.1007/s00210-026-05164-5
BibTeX
@article{Shaikh2026,
author = {Shaikh, Abdul Rashid and Mobashar, Aisha and Sharif, Ali and Akhtar, Bushra and Alghamdi, Ohoud A and Alyami, Esmael M and Elossaily, Gehan M and Almohammed, Omar A and Metouekel, Amira and Bourhia, Mohammed},
title = {Exploring the anti-asthmatic effects of HMM: OVA-induced murine model and multi-target in silico analysis},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2026},
volume = {399},
number = {9},
pages = {14221--14235},
doi = {10.1007/s00210-026-05164-5}
}
EUVIMED